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ABSTRACT 
Reversed-phase chromatography is the mainly used in chromatographic mode, it is used to separate neutral molecules in solution based o n 
their hydrophobicity. This technique is the reverse of normal-phase chromatography in the intelligence that it involves the employ of a polar 
mobile phase and a non-polar stationary phase. A sensitive, accurate, rapid, cost effective and robust HPLC method was developed for the 
quantification of Saxagliptin Hydrochloride (SGH) with UV detector. In this method, a reversed-phase Grace C18 (250mm x 4.6ID, Particle size: 
5 micron) column with a mobile phase of methanol: water (80:20; v/v) at 0.8ml/min flow rate was used to separate SGH with a detection of 
212nm.The volume injected was 20 µL. The retention time of SGH was obtained as 4.196 min. Hence it can be applied for routine analysis of 
Saxagliptin Hydrochloride (SGH) in bulk drug.  
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1. INTRODUCTION 
Analytical chemistry termed as science of determining the 
components of materials in terms of the elements or 
compound contained. The techniques of this science are used 
to identify the substances which may be present in a material 
and to determine the exact amounts of the identified 
substances. Analytical chemistry is important in nearly all 
aspects of chemistry, e.g. clinical, agricultural, 
environmental, forensic, manufacturing metallurgical and 
pharmaceutical chemistry. Analytical techniques proved in 
assuring and maintaining the quality of substance and are 
critical components of QA and QC1, 2. 
Analytical method should be,  
1. Most productive, economical and convenient, 
2. As accurate and precise as required, 
3. As simple as possible, 
4. Most specific 
Should be fully optimized before transfer for validation of its 
characteristics such as precision, accuracy, sensitivity etc.2 
According  to  USP,  system  suitability  tests  are  integral  
part  of  chromatographic methods.  These  tests  are  used  to  
verify  that  the  reproducibility  and  resolution  of  the 
system are adequate for the analysis to be performed. 
Parameters such as plate count, tailing  factor,  resolution  
and  reproducibility  (%RSD  retention  time  and  area  for  6 
repetitions)  are  determined  and  compared  against  the  
specifications  set  for  the method.3, 4 
Now a day reversed-phase chromatography is the most 
commonly used separation technique in HPLC due to its 
broad application range. It is estimated that over 65% 
(possibly up to 90%) of all HPLC separations are carried out 
in the reversed phase mode. The reasons for this include the 
simplicity, versatility, and scope of the reversed-phase 
method as it is able to handle compounds of a diverse 
polarity and molecular mass5-7. 
Reversed phase chromatography has found both analytical 
and preparative applications in the area of biochemical 
separation and purification. Molecules that possess some 
degree of hydrophobic character can be separated by 
reversed phase chromatography with excellent recovery and 
resolution8. The separation mechanism in reversed phase 
chromatography depends on the hydrophobic binding 
interaction between the solute molecule in the mobile phase 
and the immobilised hydrophobic ligand, i.e. the stationary 
phase. The actual nature of the hydrophobic binding 
interaction itself is a matter of heated debate9 but the 
conventional wisdom assumes the binding interaction to be 
the result of a favourable entropy effect. 
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2. AIM AND OBJECTIVE 
Aim:  
Analytical method development and validation of Saxagliptin 
HCL by RP-HPLC method. 
Objectives: 
1. To develop a simple validated stability indicating method 
for the estimation for Saxagliptin HCL by RP-HPLC. 
2. To validate methods as per ICH guidelines. 
3. MATERIALS AND METHOD 
3.1. UV Spectroscopic Method 
Selection of Wavelength: Weighed accurately about 10mg of 
working standard of Saxagliptin HCl and transferred in 10mL 
of volumetric flask. Added about 5mL of diluent, Sonicated to 
dissolve and volume was made up the mark with diluent. 
Further diluted 0.2mL of above solution to 10mL and volume 
was made up to the mark with diluent. 
Determination of λmax 10-11 
Initially the Ultra violet (U.V) spectrum of Saxagliptin HCl 
was produced using appropriate U.V spectrophotometer, so 
as to determine the absorbance maxima or Lambda max (λ 
max). This is essential since HPLC detection is basically UV 
based, thus a 20ppm solution of Saxagliptin HCl in water was 
used to get the following spectra.  
3.2 High Performance Liquid Chromatography Method 
Development by RP-HPLC 
Preparation of Saxagliptin HCl Standard:12-17 
Weighed accurately about 10mg of Saxagliptin HCl standard 
and transffered into 10mL of volumetric flask, added about 
5mL of diluent, shaked to dissolved and volume was made up 
to the mark with diluent. ( concentration of Saxagliptin HCl 
1000ppm). 
Further diluted 0.5mL of above stock solution to 10mL of 
volumetric flask and volume was made up to the mark with 
diluent (concentration of Saxagliptin HCl 50ppm). 
                                                                                      
Trial 1  
Table 3.1: Chromatographic conditions for Trial 1 
Column  Grace C18 (250mm x 4.6ID, Particle size: 5 micron) 
Mobile Phase Methanol : Buffer (70:30) 
Pump mode Isocratic 
Flow rate 0.8ml/min 
Detector UV- Detector 
Injection volume 20µL 
Column Temperature 25°C 
Wavelength 212nm 
Run time 7.71min 
 
Preparation of Buffer:  0.136gm of Potassium dihydrogen phosphate dissolved in 100mL of distilled water, gives 10mM 
solution. 
Trial 2  
Table 3.2: Chromatographic conditions for Trial 2 
Column  Grace C18 (250mm x 4.6ID, Particle size: 5 micron) 
Mobile Phase Methanol : Buffer (80:20) 
Pump mode Isocratic 
Flow rate 0.8ml/min 
Detector UV- Detector 
Injection volume 20µL 
Column Temperature 25°C 
Wavelength 212nm 
Run time 6.88min 
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Trial 3 
Table 3.3: Chromatographic conditions for Trial 3 
Column  Grace C18 (250mm x 4.6ID, Particle size: 5 micron) 
Mobile Phase Methanol : Water (80:20) 
Pump mode Isocratic 
Flow rate 0.8ml/min 
Detector UV- Detector 
Injection volume 20µL 
Column Temperature 25°C 
Wavelength 212nm 
Run time 9.21min 
 
Trial 4 
Table 3.4: Chromatographic conditions for Trial 4 
Column  Grace C18 (250mm x 4.6ID, Particle size: 5 micron) 
Mobile Phase Methanol : Water (80:20) 
Pump mode Isocratic 
Flow rate 0.8ml/min 
Detector UV- Detector 
Injection volume 20µL 
Column Temperature 25°C 
Wavelength 212nm 
Run time 7.15min 
 
TABLE 4.1: FINAL METHOD FOR ASSAY 
PARAMETER CONDITIONS 
Stationary Phase (Column)  Grace C18 (250mm x 4.6ID, Particle size: 5 micron) 
Mobile Phase Methanol: Water (80:20) 
Diluent Methanol : Water (200:100) 
Flow rate 0.8ml/min 
Injection volume 20 µL 
Pump mode Isocratic  
Detector PDA 
Wavelength 212nm 
Column Temperature 25°C 
Run Time 7.15 min 
Retention Time 4.195 
 
Conclusion: 
The peak obtained in Trail 4 is sharper. Shape is better. The retention time of the Trial 4 was less i.e. 4.165’ 
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4. RESULT AND DISCUSSION 
 
Figure 1.2: UV spectra of Saxagliptin HCl 
 
Figure 3.2: Observed chromatogram of Trial 1 
 
Figure 3.3: Observed chromatogram of Trial 2 
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Figure 3.4: Observed Chromatogram of Trial 3 
 
Figure 3.5: Observed Chromatogram of Trial 4 
 
5. CONCLUSION 
The present investigation is an attempt to develop method 
for estimation of saxagliptin HCl in bulk by RP-HPLC. The 
developed method is less costly with lower retention time 
than the method reported so far. The developed methods 
will be useful in the estimation of Saxagliptin HCl in bulk in 
future. 
6. REFERENCES 
1. Skoog DA, Holler FJ, Timothy A, Nieman NW. Principle of 
Instrumental Analysis.  5th edition. Bangalore: Eastern press, 
2004, 678-688, 695-696.  
2. Christian G, Analytical Chemistry, 5thedition, New York, John 
Wiley and Sons, 2003, 1-3 
3. Willard HH, Merritt LL, Dean JA, Settle FA, Instrumental 
methods of analysis. 7th edition. New Delhi: CBS Publishers 
and Distributors; 2001, 465-506, 513-522, 530-534. 
4. Backett H, Stanlake JB. Practical Pharmaceutical Chemistry 
part II. 4th edition. Delhi: CBS Publisher and Distributors; 
2001, 255-280. 
5.         Willard HH, Dean AJ. Instrumental Methods of Analysis. CBS 
Publishers and distributors, 7th edition 1986, 513-515, 580-
604.  
6.         Connors AK. A Text Book of Pharmaceutical Analysis. A Wiley 
Interscience publication, 3rd edition, 2005, 373-400. 
7.         Ahuja S, Ahuja S. High Pressure Liquid Chromatography. 
Comprehensive Analytical Chemistry. Elsevier, 2006.  
8.         Amesham Biosciences. Reversed Phase Chromatography. 
Principles and Methods. 6-8.  
9.         Dorsey JG, Cooper WT. Retention mechanisms of bonded-
phase liquid chromatography. Anal. Chem. 66th edition 1994, 
857A-867A. 
10. ICH Q2 (R1),    Harmonized   tripartite   guideline,   validation   
of   analytical procedure methodology, IFPMA, proceedings of 
the international conference on harmonization, Geneva, 2005. 
11. ICH (Q2A), Harmonized   tripartite   guideline, validation   of   
analytical procedure methodology, IFPMA, proceedings of the 
international conference on harmonization, Geneva, 1994. 
12. ICH-Q2A, (R1) Text on Validation of Analytical Procedures, 
U.S. Department of Health and Human Services. USFDA. 1995. 
A1- A13. 
13.  Pallavi et al. / SGVU Journal of Pharmaceutical Research & 
Education, 2017, 1(2), 243-260 
14. Md. Saiful Islam, et al, (2016), Development and validation of 
RP-HPLC method for determination of saxagliptin hcl in bulk 
and tablet dosage form, World journal of pharmacy and 
pharmaceutical sciences, Volume 5, Issue 5, 107-119. 
15. P.B.N. Prasad, et al, (2015), Development and validation of a 
method for simultaneous determination of metformin and 
saxagliptin in a formulation by RP-HPLC, American journal of 
analytical chemistry, 2015, 6, 841-850. 
16. Hanan A. Merey, et al, (2017), Chromatographic methods for 
the simultaneous determination of binary mixture of 
saxagliptin hcl and metformin hcl, Bulletin of faculty of 
pharmacy, Cairo university, 55 (2017) 311-317. 
17. Dr. Advaita B. Patel, et al, (2017), Development and validation 
of stability indicating method for the for the simultaneous 
estimation of saxagliptin hcl and dapagliflozin using RP-HPLC 
method in tablet dosage form, World journal of pharmacy and 
pharmaceutical sciences, Volume 6, Issue 10, 444-458.
 
4
.1
9
6
'
0
2 0
40
60
80
100
120
140
160
mV
2 4 6 8 10 12 14 16 18 min
4
.1
9
5
'
0
9 0
180
270
360
450
540
630
720
810
mV
2 4 6 8 10 12 14 16 18 min
